• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Melanoma immunotherapy trial shows some improvement in survival

Article

London - Researchers in Australia reporting on an immunotherapy trial with vaccinia viral melanoma cell lysates in patients with stage IIb and III melanoma say that finding an effective adjuvant treatment for melanoma is proving to be a challenge.

Related Videos
Related Content
Mobile Health Technologies In Studies of Actinic Keratosis Do Not Compromise Patient Safety, Research Article Says

Mobile Health Technologies In Studies of Actinic Keratosis Do Not Compromise Patient Safety, Research Article Says

Article
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment

Podcast
Introducing Omar Noor, MD, FAAD: Dermatology Times' Newest Editorial Advisory Board Member

Introducing Omar Noor, MD, FAAD: Dermatology Times' Newest Editorial Advisory Board Member

Article
ReV Up Your Vitiligo Treatment Strategies

ReV Up Your Vitiligo Treatment Strategies

Podcast
Variable-Sequenced Large-Spot KTP and PDL Demonstrate Comparable Efficacy in Rosacea

Variable-Sequenced Large-Spot KTP and PDL Demonstrate Comparable Efficacy in Rosacea

Article
Guselkumab Demonstrates Significant Improvement in Psoriasis Symptoms and HRQoL, Reduces Sexual Impairment and Stigmatization

Guselkumab Demonstrates Significant Improvement in Psoriasis Symptoms and HRQoL, Reduces Sexual Impairment and Stigmatization

Article
© 2024 MJH Life Sciences

All rights reserved.